Skip to content

Value & Innovation

Value & Innovation
Harvard Business Review

We Need a Global System for Testing and Approving Cancer Treatments

Article
Value & Innovation
AHRQ

Improving Healthcare Through AHRQ’s Digital Healthcare Research Program

Report
Value & Innovation
Alliance for Patient Access

Accelerated Approval

Fast Facts
Value & Innovation
STAT

In reversal, FDA advisers vote to support approval of Amylyx’s drug for ALS

Article
Value & Innovation
Brookings

How three big bills in Congress will spur innovation and competitiveness

Podcast/Article
Value & Innovation
Drug Channels Institute

Specialty Drugs Update: Trends, Controversies, and Outlook

Webinar
Value & Innovation
Tufts Cost-Effectiveness Analysis Registry

When are breakthrough therapies cost-effective?

Published Paper